Suchergebnisse - Nathan Vastesaeger

  • Treffer 1 - 13 von 13
Treffer weiter einschränken
  1. 1
    Classification and management of allergic rhinitis patients in general practice during pollen season

    Classification and management of allergic rhinitis patients in general practice during pollen season von Helen Van Hoecke, Nathan Vastesaeger, L Dewulf, Lien Sys, Paul Van Cauwenberge

    Veröffentlicht 2006
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis

    A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis von Nathan Vastesaeger, Stephen Xu, Daniel Aletaha, E. William St. Clair, Josef S Smolen

    Veröffentlicht 2009
    Volltext Volltext
    Revisão
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study

    Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study von Asta Baranauskaitė, Helena Raffayová, Nikolay V. Kungurov, А. А. Кубанова, Algirdas Venalis, Laszlo Helmle, Shankar Srinivasan, Е. Л. Насонов, Nathan Vastesaeger

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFAST study, Part 1

    Efficacy and safety of infliximab plus naproxen versus naproxen alone in patients with early, active axial spondyloarthritis: results from the double-blind, placebo-controlled INFA... von Joachim Sieper, Jan Lenaerts, J. Wollenhaupt, Martín Rudwaleit, Mazurov Vi, L. Myasoutova, S Park, Yeong Wook Song, R. Yao, D. K. Chitkara, Nathan Vastesaeger

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-up study, INFAST Part 2

    Maintenance of biologic-free remission with naproxen or no treatment in patients with early, active axial spondyloarthritis: results from a 6-month, randomised, open-label follow-u... von Joachim Sieper, Jan Lenaerts, J. Wollenhaupt, Martín Rudwaleit, Mazurov Vi, L. Myasoutova, S Park, Yeong Wook Song, R. Yao, D. K. Chitkara, Nathan Vastesaeger

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome

    Spinal Radiographic Changes in Ankylosing Spondylitis: Association with Clinical Characteristics and Functional Outcome von Annelies Boonen, Bert Vander Cruyssen, K de Vlam, Serge Steinfeld, Clio Ribbens, Jan Lenaerts, Filip Van den Bosch, Herman Mielants, L Dewulf, Nathan Vastesaeger

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice

    The epidemiology of ankylosing spondylitis and the commencement of anti-TNF therapy in daily rheumatology practice von Bert Vander Cruyssen, C. Ribbens, A. Boonen, Herman Mielants, Kurt de Vlam, J. Lenaerts, Serge Steinfeld, Filip Van den Bosch, L Dewulf, Nathan Vastesaeger

    Veröffentlicht 2007
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery

    Hip involvement in ankylosing spondylitis: epidemiology and risk factors associated with hip replacement surgery von Bert Vander Cruyssen, Elisa Muñoz-Gomáriz, Pilar Font, Juan Mulero, K de Vlam, Annelies Boonen, Janitzia Vázquez‐Mellado, D. Flores, Nathan Vastesaeger, Eduardo Collantes‐Estévez

    Veröffentlicht 2009
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study

    Efficacy and safety of golimumab as add-on therapy to disease-modifying antirheumatic drugs: results of the GO-MORE study von Bernard Combe, Bhaskar Dasgupta, Ingrid Louw, Sarvajeet Pal, J. Wollenhaupt, Cristiano A. F. Zerbini, André Beaulieu, Hendrik Schulze‐Koops, Patrick Durez, Ruji Yao, Nathan Vastesaeger, Haoling H. Weng

    Veröffentlicht 2013
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    THU0155 Predictors of Low Disease Activity and Remission after One Dose of Golimumab in Patients with Rheumatoid Arthritis

    THU0155 Predictors of Low Disease Activity and Remission after One Dose of Golimumab in Patients with Rheumatoid Arthritis von Bhaskar Dasgupta, Bernard Combe, Patrick Durez, Hendrik Schulze‐Koops, Ingrid Louw, J. Wollenhaupt, Cristiano A. F. Zerbini, A. D. Beaulieu, R. Yao, Susan Huyck, Marcello Govoni, Hsu‐Huei Weng, Nathan Vastesaeger

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Predicting the outcome of ankylosing spondylitis therapy

    Predicting the outcome of ankylosing spondylitis therapy von Nathan Vastesaeger, Désirée van der Heijde, Robert D. Inman, Yanxin Wang, Atul Deodhar, Benjamin Hsu, Mahboob U. Rahman, Ben A. C. Dijkmans, Piet Geusens, Bert Vander Cruyssen, Eduardo Collantes‐Estévez, Joachim Sieper, Jürgen Braun

    Veröffentlicht 2011
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab treatment

    DAS28 best reflects the physician's clinical judgment of response to infliximab therapy in rheumatoid arthritis patients: validation of the DAS28 score in patients under infliximab... von Bert Vander Cruyssen, Stijn Van Looy, Bart Wyns, René Westhovens, Patrick Durez, Filip Van den Bosch, Eric Veys, Herman Mielants, Luc S. De Clerck, Anne Peretz, Michel Malaise, Leon Verbruggen, Nathan Vastesaeger, Anja Geldhof, Luc Boullart, Filip De Keyser

    Veröffentlicht 2005
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab

    Prediction of remission and low disease activity in disease-modifying anti-rheumatic drug-refractory patients with rheumatoid arthritis treated with golimumab von Nathan Vastesaeger, Abraham García Kutzbach, Howard Amital, Karel Pavelká, María Alicia Lázaro, Robert J. Moots, J. Wollenhaupt, Cristiano A. F. Zerbini, Ingrid Louw, Bernard Combe, André Beaulieu, Hendrik Schulze‐Koops, Bhaskar Dasgupta, Bo Fu, Susan Huyck, Haoling H. Weng, Marinella Govoni, Patrick Durez

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: